G. Targher et al., THE WHITE BLOOD-CELL COUNT - ITS RELATIONSHIP TO PLASMA-INSULIN AND OTHER CARDIOVASCULAR RISK-FACTORS IN HEALTHY MALE INDIVIDUALS, Journal of internal medicine, 239(5), 1996, pp. 435-441
Objectives. To evaluate the relationships of total and differential wh
ite blood cell (WBC) count to the components of the so-called insulin
resistance syndrome. Subjects and design. The study population consist
ed of a random sample of 90 38-year-old healthy men with normal glucos
e tolerance. Interventions. A 75 g oral glucose tolerance test was per
formed in all participants. Main outcome measures. Total and different
ial WBC count, lipids, blood pressure, plasma glucose, C-peptide and i
nsulin (at fasting and 2 h after glucose load). Results. Total WBC cou
nt correlated consistently with plasma 2-h glucose (r = 0.38; P < 0.00
1), fasting and 2-h postload insulin (r = 0.26 and r = 0.33; P < 0.01-
0.001, respectively) and C-peptide (r = 0.28 and r = 0.32: P < 0.01-0.
001) concentrations. Smokers had significantly higher total leukocytes
(P < 0.01), neutrophils and lymphocytes than nonsmokers. Furthermore,
total WBC count correlated positively with body mass index, blood pre
ssure, plasma triglycerides, fibrinogen, and negatively with HDL chole
sterol concentration. As differential WBC count, most variables correl
ated essentially to neutrophils and/or lymphocytes, whereas plasma ins
ulin and C-peptide concentrations correlated essentially to lymphocyte
s and monocytes, but not to neutrophils. In a multiple linear regressi
on analysis, only 2-h plasma glucose (P < 0.01) and fibrinogen (P < 0.
05) were positive predictors of total WBC count after adjusting for al
l potentially confounding variables. Conclusions. The results indicate
that increased, albeit normal, WBC count associates with the cluster
of metabolic and haemodynamic disorders typical of the insulin resista
nce syndrome, and suggest that increased WBC count may be yet another
component of this syndrome.